查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970696

氣喘監測設備市場－全球產業規模、佔有率、趨勢、機會、預測：按設備、最終用戶、地區和競爭對手分類，2021-2031年

Asthma Monitoring Device Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Device, By End-User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球氣喘監測設備市場預計將從 2025 年的 3.0298 億美元成長到 2031 年的 4.3615 億美元，複合年成長率為 6.26%。

該領域以智慧吸入器和峰值流量計等專用設備為特徵，這些設備對於評估肺功能和追蹤呼吸道症狀至關重要。推動該領域成長的主要因素是全球慢性呼吸系統疾病發病率的上升以及遠端患者管理技術的整合發展。這些因素導致市場對可靠的疾病管理解決方案的需求持續存在，而非出現暫時的市場波動。

市場概覽
預測期 2027-2031
市場規模：2025年 3.0298億美元
市場規模：2031年 4.3615億美元
複合年成長率：2026-2031年 6.26%
成長最快的細分市場 智慧吸入器
最大的市場 北美洲

儘管取得了這些積極進展，但由於先進數位監測系統高成本以及新興市場缺乏完善的報銷政策，市場仍面臨許多障礙。根據全球氣喘舉措（GIIA）的數據，到2024年，全球將有超過2.6億人患有氣喘，凸顯了對價格合理的監測方案的迫切需求。目前，經濟限制使得相當一部分患者無法獲得現代技術支持，阻礙了市場的廣泛普及。

市場促進因素

氣喘和其他慢性呼吸系統疾病的日益增加是推動監測設備市場發展的主要動力，尤其是在環境問題嚴重的地區。美國肺臟協會2024年報告稱，美國約有1.312億人居住在污染程度不健康的地區，凸顯了嚴格追蹤症狀以降低健康風險的緊迫性。此外，根據美國氣喘和過敏基金會發布的《2024年氣喘高發地區報告》，約有2,800萬美國人患有氣喘，凸顯了對持續家庭監測解決方案的巨大需求。

隨著市場需求的成長，智慧吸入器和數位健康平台的技術創新正在透過實現數據驅動的預防性護理來變革整個產業。這些先進設備能夠與雲端系統無縫整合，即時監測患者的用藥依從性，顯著提升患者自我管理的能力。阿斯特捷利康2024年年度報告也印證了這一趨勢，該報告顯示其呼吸系統和免疫學部門的收入成長了23%。這表明，在採用互聯醫療生態系統的推動下，產業正實現強勁成長，該系統能夠減少患者再入院率並改善臨床決策。

市場挑戰

全球氣喘監測設備市場成長的主要障礙在於先進數位監測系統成本高且醫保報銷機制有限。儘管這些技術具備卓越的追蹤功能，但其高昂的價格使許多人難以負擔，尤其是在新興經濟體，患者往往需要自費。因此，面臨經濟困難的患者通常會優先購買必需藥物而非輔助監測設備，這阻礙了低收入群體充分發揮其市場潛力。

氣喘對醫療保健系統和個人帶來的巨大經濟負擔，進一步凸顯了這個經濟障礙的嚴重性。根據氣喘與過敏基金會統計，2024年美國氣喘的年度經濟成本超過820億美元。如此巨額的支出凸顯了醫療保健體系的負擔，使得支付方和醫療服務提供方在缺乏全面保險支援的情況下，難以證明高性能監測設備的額外成本是合理的。因此，在對成本敏感的地區，市場擴張停滯不前。

市場趨勢

市場正經歷著一場根本性的轉變，即從回顧性症狀記錄轉向主動疾病預測，將人工智慧 (AI) 應用於預測性氣喘發作分析。先進的演算法能夠分析呼吸模式，並在出現身體症狀之前預測氣喘發作，從而實現預防性干預，降低住院風險。例如，根據 MPO 雜誌 2024 年 12 月報道，Albus Health 的新型非接觸式設備利用人工智慧技術檢測早期預警訊號，並提前五天預測氣喘發作。這使得監測工具轉變為關鍵的早期預警系統。

同時，將即時病患資料整合到電子健康記錄中，利用現有醫療基礎設施中的被動式數位標記，提高了醫療服務的可近性。這種方法利用常規收集的健康數據來識別風險等級，無需為每位患者配備昂貴的專用硬體，從而繞過了經濟障礙。根據 Docwire News 2025 年 7 月報道，一項涉及約 7 萬名兒童的研究表明，被動式數位標記比傳統方法能更準確地預測氣喘風險。這使得先進的監測技術得以普及，並實現了可擴展的疾病管理。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球氣喘監測設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依設備分類（肺計量計、智慧吸入器、峰值流量計）
    • 依最終使用者（醫院/診所、居家醫療、診斷檢查室）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美氣喘監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲氣喘監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區氣喘監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲氣喘監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲氣喘監測設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球氣喘監測設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips NV
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20032

The Global Asthma Monitoring Device Market is projected to expand from USD 302.98 Million in 2025 to USD 436.15 Million by 2031, registering a CAGR of 6.26%. This sector is defined by specialized instruments such as smart inhalers and peak flow meters, which are essential for assessing lung function and tracking respiratory symptoms. Growth is primarily propelled by the rising global incidence of chronic respiratory conditions and the increasing integration of remote patient management technologies, factors that generate a consistent demand for reliable disease control solutions rather than temporary market fluctuations.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 302.98 MIllion
Market Size 2031USD 436.15 MIllion
CAGR 2026-20316.26%
Fastest Growing SegmentSmart Inhalers
Largest MarketNorth America

Despite this positive trajectory, the market faces significant hurdles due to the high costs associated with advanced digital monitoring systems and the lack of adequate reimbursement policies in emerging economies. Data from the Global Initiative for Asthma indicates that over 260 million people worldwide suffered from the disease in 2024, highlighting a critical need for affordable monitoring options. Currently, economic constraints prevent a substantial portion of this patient population from accessing modern technological aids, thereby limiting broader market penetration.

Market Driver

The increasing prevalence of asthma and other chronic respiratory diseases acts as the central force propelling the monitoring device market, particularly in regions burdened by environmental issues. In 2024, the American Lung Association reported that roughly 131.2 million people in the United States resided in areas with unhealthy pollution levels, creating an urgent necessity for rigorous symptom tracking to mitigate health risks. Furthermore, the Asthma and Allergy Foundation of America's 'Asthma Capitals 2024 Report' revealed that nearly 28 million Americans are living with asthma, underscoring the immense scale of the demand for continuous home-based monitoring solutions.

Parallel to this demand, technological innovation in smart inhalers and digital health platforms is revolutionizing the industry by enabling proactive, data-centric care. These modern devices integrate seamlessly with cloud systems to monitor medication adherence in real-time, greatly enhancing patient self-management. This trend is reflected in AstraZeneca's 2024 Annual Report, which noted a 23% revenue increase in their Respiratory & Immunology division, signaling strong industrial growth driven by the adoption of connected care ecosystems that reduce hospital readmissions and improve clinical decision-making.

Market Challenge

A primary obstacle restricting the growth of the Global Asthma Monitoring Device Market is the prohibitive cost of advanced digital monitoring systems combined with limited reimbursement frameworks. Although these technologies provide superior tracking capabilities, their high price points make them inaccessible to a large demographic, especially in emerging economies where patients often rely on out-of-pocket payments. Consequently, when faced with financial constraints, patients typically prioritize purchasing essential medications over acquiring supplementary monitoring tools, effectively preventing the market from realizing its full volume potential across less affluent populations.

The gravity of this economic barrier is further illuminated by the substantial financial burden asthma places on healthcare systems and individuals. According to the Asthma and Allergy Foundation of America, the annual economic cost of asthma in the United States exceeded $82 billion in 2024. This immense figure underscores the strain on the healthcare ecosystem, making it challenging for payers and providers to justify the additional expense of high-end monitoring devices without comprehensive insurance support, thereby stalling market expansion in cost-sensitive regions.

Market Trends

The market is witnessing a fundamental shift toward the Integration of Artificial Intelligence for Predictive Exacerbation Analytics, moving beyond reactive symptom recording to proactive disease forecasting. Advanced algorithms now analyze respiratory patterns to predict attacks before physical symptoms appear, facilitating preemptive interventions that reduce hospitalization risks. For instance, MPO Magazine reported in December 2024 that a new non-contact device by Albus Health utilizes AI to detect early warning signs and predict asthma exacerbations up to five days in advance, transforming monitoring tools into critical early-warning systems.

Simultaneously, the Integration of Real-Time Patient Data into Electronic Health Records is enhancing accessibility by utilizing passive digital markers within existing medical infrastructures. This approach leverages routinely collected health data to identify risk levels without necessitating expensive standalone hardware for every patient, thus circumventing economic barriers. As highlighted by Docwire News in July 2025, a study of nearly 70,000 children demonstrated that passive digital markers could predict asthma risks more accurately than traditional methods, effectively democratizing advanced monitoring and enabling scalable disease management.

Key Market Players

  • COSMED srl.
  • Teleflex Incorporated.
  • SCHILLER.
  • Hill-Rom, Inc.
  • Koninklijke Philips N.V.
  • ICU Medical, Inc.
  • SDI Diagnostics
  • AstraZeneca plc.
  • Merck & Co., Inc

Report Scope

In this report, the Global Asthma Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Monitoring Device Market, By Device

  • Spirometer
  • Smart Inhalers
  • Peak Flow Meter

Asthma Monitoring Device Market, By End-User

  • Hospitals & Clinics
  • Homecare
  • Diagnostic Laboratories

Asthma Monitoring Device Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Monitoring Device Market.

Available Customizations:

Global Asthma Monitoring Device Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Monitoring Device Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device (Spirometer, Smart Inhalers, Peak Flow Meter)
    • 5.2.2. By End-User (Hospitals & Clinics, Homecare, Diagnostic Laboratories)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Asthma Monitoring Device Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Asthma Monitoring Device Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Asthma Monitoring Device Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Asthma Monitoring Device Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device
        • 6.3.3.2.2. By End-User

7. Europe Asthma Monitoring Device Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Asthma Monitoring Device Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device
        • 7.3.1.2.2. By End-User
    • 7.3.2. France Asthma Monitoring Device Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device
        • 7.3.2.2.2. By End-User
    • 7.3.3. United Kingdom Asthma Monitoring Device Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device
        • 7.3.3.2.2. By End-User
    • 7.3.4. Italy Asthma Monitoring Device Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Asthma Monitoring Device Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device
        • 7.3.5.2.2. By End-User

8. Asia Pacific Asthma Monitoring Device Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Asthma Monitoring Device Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Asthma Monitoring Device Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Asthma Monitoring Device Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Asthma Monitoring Device Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Asthma Monitoring Device Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device
        • 8.3.5.2.2. By End-User

9. Middle East & Africa Asthma Monitoring Device Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Asthma Monitoring Device Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device
        • 9.3.1.2.2. By End-User
    • 9.3.2. UAE Asthma Monitoring Device Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device
        • 9.3.2.2.2. By End-User
    • 9.3.3. South Africa Asthma Monitoring Device Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device
        • 9.3.3.2.2. By End-User

10. South America Asthma Monitoring Device Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Asthma Monitoring Device Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device
        • 10.3.1.2.2. By End-User
    • 10.3.2. Colombia Asthma Monitoring Device Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device
        • 10.3.2.2.2. By End-User
    • 10.3.3. Argentina Asthma Monitoring Device Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Asthma Monitoring Device Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. COSMED srl.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Teleflex Incorporated.
  • 15.3. SCHILLER.
  • 15.4. Hill-Rom, Inc.
  • 15.5. Koninklijke Philips N.V.
  • 15.6. ICU Medical, Inc.
  • 15.7. SDI Diagnostics
  • 15.8. AstraZeneca plc.
  • 15.9. Merck & Co., Inc

16. Strategic Recommendations

17. About Us & Disclaimer